Home > Insider Trading > Filing (0001493152-22-033283)

Filing Details

Accession Number:: 0001493152-22-033283
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-22 13:54:16
Reporting Period:: 2022-08-31

Accepted Time:: 2022-11-22 13:54:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1712762	Bioaffinity Technologies Inc.	BIAF	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1481928	Maria Zannes	19702 Bella Loma, #6005 San Antonio TX 78256	President, Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-08-31	16,326	$0.00	19,897	No	4	P	Direct
Common Stock	Acquisiton	2022-09-06	23,672	$4.20	43,569	No	4	C	Direct
Common Stock	Acquisiton	2022-11-17	18,099	$0.00	61,668	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	C	Direct
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (right to buy)	Acquisiton	2022-08-31	16,326	$0.00	16,326	$7.35
Common Stock	Non-tradeable Warrants (right to buy)	Acquisiton	2022-08-31	16,326	$0.00	16,326	$7.66
Common Stock	Unsecured Convertible Promissory Note	Disposition	2022-09-06	0	$0.00	23,672	$4.20
Common Stock	Warrants (right to buy)	Acquisiton	2022-09-06	23,571	$0.00	23,571	$6.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,326	2022-08-31	2027-08-31	No	4	P	Direct
16,326	2022-08-31	2027-08-31	No	4	P	Direct
0	2022-09-06	2022-10-31	No	4	C	Direct
23,571	2022-09-06	2027-08-11	No	4	A	Direct

Footnotes

The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the "Common Stock"), of bioAffinity Technologies, Inc. (the "Issuer"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the "IPO").
The reported securities are included within 16,326 Units purchased by Ms. Zannes for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share.
In connection with the IPO closing on September 6, 2022, the $99,423.12 of outstanding principal and accrued but unpaid interest of Ms. Zannes's unsecured convertible promissory note, dated August 11, 2022, automatically converted into 23,672 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
Represents a right to purchase 23,571 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Ms. Zannes on August 11, 2022 as consideration for funds Ms. Zannes paid to the Issuer for her unsecured convertible promissory note, dated August 11, 2022.
Represents a grant from the Issuer to Ms. Zannes of 18,099 restricted shares of Common Stock on November 17, 2022 under the Issuer's 2014 Equity Incentive Plan. The restricted stock will begin vesting on December 17, 2022 in 12 monthly installments, the first 11 of which will be of 1,508 shares of Common Stock and the last of which will be of the remaining 1,511 shares of Common Stock, subject to Ms. Zannes's continuous service to the Issuer through each vesting date.